Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Review Article | By Y Ahmada, JP Howardb, MV Madhavan et al.

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

Editorial | By JG Howlett.

The Year in Cardiovascular Medicine 2020: Coronary Prevention: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of coronary prevention is Professor Ramon Estruch, Dr Luis Ruilope, and Professor Francesco Cosentino. Mark Nicholls meets them

Expert Opinion | By M Nicholls.

The Year in Cardiovascular Medicine 2020: Valvular Heart Disease: Discussing the Year in Cardiovascular Medicine for 2020 in the field of valvular heart disease is Professor Helmut Baumgartner and Dr Javier Bermejo. Mark Nicholls reports

Expert Opinion | By M Nicholls.

The Year in Cardiovascular Medicine 2020: Imaging: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of imaging are Fausto Pinto, José Luis Zamorano and Chiara Bucciarelli-Ducci. Judy Ozkan speaks with them

Expert Opinion | By J Ozkan.

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

Expert Opinion | By H Bueno, B Moura, P Lancellotti et al.

The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care

Expert Opinion | By B Ibanez, D Roque, S Price.

The Year in Cardiovascular Medicine 2020: Coronary Intervention

Expert Opinion | By M Nicholls.

The year in cardiovascular medicine 2020: interventional cardiology

Expert Opinion | By F Alfonso, N Gonzalo, F Rivero et al.

Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES

Original Research | By KH Chau , AJ Kirtane , RM Easterwood et al.